share_log

BRIEF-Syndax Announces Orphan Drug Designation Granted To Axatilimab

BRIEF-Syndax Announces Orphan Drug Designation Granted To Axatilimab

Brief-Syndax宣布授予Axatilimab孤儿药物称号
路透社 ·  2021/03/31 19:49

March 31 (Reuters) - Syndax Pharmaceuticals Inc :
   * SYNDAX ANNOUNCES ORPHAN DRUG DESIGNATION GRANTED TO AXATILIMAB FOR TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

路透3月31日电-Syndax PharmPharmticals Inc：*Syndax宣布授予AXATILIMAB孤儿药物称号，用于治疗慢性移植物抗宿主疾病Eikon的源文本：进一步的公司报道：(Reurs.Briefs@thomsonreurs.com；)

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发